Mass vaccinations will not prevent Ebolavirus outbreaks, new research shows

May 9, 2018, University of Kent
Ebola
Ebola virus. Credit: NIAID

Prophylactic mass vaccination programmes are not a realistic option in the battle to prevent new Ebolavirus outbreaks, a University of Kent-led research team has shown.

The findings come as the World Health Organisation has announced a new Ebola in the Democratic Republic of Kongo.

The team analysed the prospects for various Ebolavirus vaccines and found that, for the foreseable future at least, Ebolavirus outbreak control depends on surveillance and the isolation of cases.

The researchers' analysis revealed that very high proportions of potentially affected populations would need to be protected by vaccination to establish herd immunity, i.e. the level of immunity that prevents virus transmission within a population.

The study, entitled Herd immunity to Ebolaviruses is not a realistic target for current vaccination strategies identified that, in the critical phases of many Ebola virus outbreaks, the average infected individual infects four or more other people, which enables the virus to spread rapidly.

At this level, 80% of a population would need to be immunised to prevent outbreaks, even if a highly effective that protects 90% of individuals after vaccination was available.

Such are currently unachievable. In a vaccination trial during the West African Ebola virus epidemic, only 49% of individuals who had been in contact with Ebola virus patients could be vaccinated. Thirty-four per cent of contacts refused vaccination although they had been exposed to the disease.

There are currently no clinical vaccine candidates available that protect against all four human-pathogenic Ebolaviruses. It also remains unclear, say the researchers led by Professor Martin Michaelis, of Kent's School of Biosciences, whether the available vaccine candidates provide the long-term protection (? 10 years) that is required for the sort of prophylactic mass vaccination programme that could prevent Ebola, which becomes repeatedly introduced into the human population from animal reservoirs.

A large vaccination programme would also be costly and impractical, the study points out. Costs for current Ebolavirus vaccine candidates are estimated to be in a range of US$ 15-20 per dose, with some 462 million people living in the areas affected by Ebolavirus outbreaks, many of them in very remote rural areas.

In the absence of a realistic prophylactic mass vaccination programme, the reasearchers conclude that clinical vaccine candidates will need to be focused on health care workers who are often involved in disease transmission, potentially in combination with the vaccination of patient contacts.

Explore further: Researchers map the potential spread of yellow fever virus to cities around the world

More information: Stuart G. Masterson et al, Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies, Frontiers in Immunology (2018). DOI: 10.3389/fimmu.2018.01025

Related Stories

Researchers map the potential spread of yellow fever virus to cities around the world

April 27, 2018
The deadly yellow fever virus has the potential to spread into cities around the world where it previously hasn't been seen, according to a new study led by St. Michael's Hospital.

Parents want the HPV vaccine for their sons – new research

April 12, 2018
Human papillomavirus (HPV) is a sexually transmitted infection that causes diseases that affect both men and women. In the UK, girls are vaccinated against HPV but boys are not.

Study announces a durable vaccine for Ebola

March 25, 2015
A cytomegalovirus (CMV)-based vaccine provides long-lasting protective immunity against Ebola virus, and has potential for development as a disseminating vaccine strategy to prevent ebolavirus infection of wild African ape ...

Annual influenza vaccination does not prevent natural immunity

November 14, 2017
Earlier studies have suggested that having repeated annual influenza vaccination can prevent natural immunity to the virus, and potentially increase the susceptibility to influenza illness in the event of a pandemic, or when ...

Ebola vaccines provide immune responses after one year

March 14, 2017
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

Maternally acquired Zika immunity can increase dengue disease severity in mouse pups

November 14, 2018
To say that the immune system is complex is an understatement: an immune response protective in one context can turn deadly over time, as evidenced by numerous epidemiological studies on dengue infection, spanning multiple ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.